LIVE NEWS UPDATE

Indian Pharma Live News

Latest pharmaceutical, regulatory, research and business developments from across India's pharma industry.

LIVE
🇮🇳 INDIAN NEWS
ThePrintDrug price caps can’t stop at cancer medicines. India needs to regulate pharma margins - ThePrint The Economic TimesIndia's pharma exports rise 4.9% to USD 16.14 bn in H1; shipments to Europe up nearly 10%: Pharmexcil - The Economic Times TheWire.inSCHOTT Pharma India Marks a New Chapter, Building on Its Strong India Presence and Global Capabilities - TheWire.in Business StandardIndia's pharma, healthcare deal volumes rise 23% in Q3 2026: Report - Business Standard India Education DiaryGranules India’s Pharma Pathashala Creates Pathways for Youth - India Education Diary eHealth MagazineSenores Pharmaceuticals Plans ₹43 Crore Capacity Expansion Across US and India, Adds Prefilled Syringe Line - eHealth Magazine BW BusinessworldIndia’s Pharma Exports Grow 4.9% To $16.14 Bn In April-September 2026 - BW Businessworld Business StandardIndia's pharma exports grow 4.9% to $16.14 bn in H1FY27 on Europe gains - Business Standard The Economic TimesSCHOTT Pharma India marks a new chapter, building on its strong national presence and global capabilities - The Economic Times BioSpectrum IndiaIndia’s pharmaceutical exports grow 4.9% to $16.14 B in H1 FY27 - BioSpectrum India ThePrintDrug price caps can’t stop at cancer medicines. India needs to regulate pharma margins - ThePrint The Economic TimesIndia's pharma exports rise 4.9% to USD 16.14 bn in H1; shipments to Europe up nearly 10%: Pharmexcil - The Economic Times TheWire.inSCHOTT Pharma India Marks a New Chapter, Building on Its Strong India Presence and Global Capabilities - TheWire.in Business StandardIndia's pharma, healthcare deal volumes rise 23% in Q3 2026: Report - Business Standard India Education DiaryGranules India’s Pharma Pathashala Creates Pathways for Youth - India Education Diary eHealth MagazineSenores Pharmaceuticals Plans ₹43 Crore Capacity Expansion Across US and India, Adds Prefilled Syringe Line - eHealth Magazine BW BusinessworldIndia’s Pharma Exports Grow 4.9% To $16.14 Bn In April-September 2026 - BW Businessworld Business StandardIndia's pharma exports grow 4.9% to $16.14 bn in H1FY27 on Europe gains - Business Standard The Economic TimesSCHOTT Pharma India marks a new chapter, building on its strong national presence and global capabilities - The Economic Times BioSpectrum IndiaIndia’s pharmaceutical exports grow 4.9% to $16.14 B in H1 FY27 - BioSpectrum India
LIVE UPDATES

Top Global Pharma News

Latest pharmaceutical, biotech and regulatory developments from leading global sources.

LIVE
TOP NEWS
The Pharma Letter What FDA and EMA now accept from real-world data - The Pharma Letter European Medicines Agency (EMA) EMA and FDA set common principles for AI in medicine development - European Medicines Agency (EMA) The Medicine Maker How China Is Rewriting the Rules Global Drug Development - The Medicine Maker Fierce Biotech The 2026 Cell Therapy Regulatory Landscape: Aligning CMC Strategy with FDA and EMA Expectations - Fierce Biotech Health Policy Watch EU And US Regulators Reach Landmark Accord On AI Principles In Drug Development - Health Policy Watch Fierce Pharma Regulatory tracker: FDA starts review of Sandoz's generic tirzepatide - Fierce Pharma Manufacturing Chemist Shilpa Biologicals commissions one of India’s very few integrated ADC drug substance GMP manufacturing facilities - Manufacturing Chemist Genetic Engineering and Biotechnology News Shilpa Commissions Integrated ADC Drug Substance GMP Manufacturing Facility - Genetic Engineering and Biotechnology News BigGo Finance Taiwan's TAHO Pharmaceuticals' Antithrombotic Oral Film Clears FDA Acceptance Hurdle, Targets World's Second-Largest Drug Market - BigGo Finance HDBuzz – Huntington’s disease research news. SOM3355 Moves Toward Phase 3 as Both EMA and FDA Signal Support - HDBuzz – Huntington’s disease research news. The Pharma Letter What FDA and EMA now accept from real-world data - The Pharma Letter European Medicines Agency (EMA) EMA and FDA set common principles for AI in medicine development - European Medicines Agency (EMA) The Medicine Maker How China Is Rewriting the Rules Global Drug Development - The Medicine Maker Fierce Biotech The 2026 Cell Therapy Regulatory Landscape: Aligning CMC Strategy with FDA and EMA Expectations - Fierce Biotech Health Policy Watch EU And US Regulators Reach Landmark Accord On AI Principles In Drug Development - Health Policy Watch Fierce Pharma Regulatory tracker: FDA starts review of Sandoz's generic tirzepatide - Fierce Pharma Manufacturing Chemist Shilpa Biologicals commissions one of India’s very few integrated ADC drug substance GMP manufacturing facilities - Manufacturing Chemist Genetic Engineering and Biotechnology News Shilpa Commissions Integrated ADC Drug Substance GMP Manufacturing Facility - Genetic Engineering and Biotechnology News BigGo Finance Taiwan's TAHO Pharmaceuticals' Antithrombotic Oral Film Clears FDA Acceptance Hurdle, Targets World's Second-Largest Drug Market - BigGo Finance HDBuzz – Huntington’s disease research news. SOM3355 Moves Toward Phase 3 as Both EMA and FDA Signal Support - HDBuzz – Huntington’s disease research news.

Addvertisement

Editorial

Rare disease drug reviews need a credible reset
Editorial
Current Article

Rare disease drug reviews need a credible reset

Author: Editorial Board
Published: October 21, 2026 • 6:44 pm
The FDA’s rare-disease review initiative could make drug development more predictable and responsive to patients’ unmet needs. VoP’s view: Greater regulatory flexibility must come with rigorous evidence, transparent decisions, and strong safety and quality standards.
Read Full Article →
History

Expert Opinion

AI Assisted Contamination Assessment in Pharmaceutical Microbiology
Expert Opinion
Current Article

AI Assisted Contamination Assessment in Pharmaceutical Microbiology

Author: Mrs. Reeta Nauriyal
Published: October 10, 2026 • 2:38 pm
This article explores how artificial intelligence can support contamination assessment, colony detection, and environmental monitoring in pharmaceutical microbiology. It highlights the need for validated methods, reliable data, and microbiologist oversight to strengthen quality control and protect product quality.
Read Full Article →
History
History 1
No history article available
More Expert Opinion articles will appear here automatically when published.
History 2
No history article available
More Expert Opinion articles will appear here automatically when published.
History 3
No history article available
More Expert Opinion articles will appear here automatically when published.

Guest Article

History
History 1
No history article available
More Guest Article articles will appear here automatically when published.
History 2
No history article available
More Guest Article articles will appear here automatically when published.
History 3
No history article available
More Guest Article articles will appear here automatically when published.

Other

Pharmaceutical Billing and HSN Classification
Other
Current Article

Pharmaceutical Billing and HSN Classification

Author: Mr. Deepak Kumar
Published: October 10, 2026 • 3:58 pm
This article examines common HSN classification and billing problems in the pharmaceutical industry, including GST mismatches, pricing errors, and expired-stock returns. It outlines practical solutions through verified product records, controlled tax updates, accurate invoicing, and regular reconciliation.
Read Full Article →
History
History 1
No history article available
More Other articles will appear here automatically when published.
History 2
No history article available
More Other articles will appear here automatically when published.
History 3
No history article available
More Other articles will appear here automatically when published.

Top-Category News Display

Vacancies In Pharma

The Story Behind Voice of Pharma

01

But its stories are scattered.

Voice of Pharma brings them together. We unify global and domestic pharmaceutical intelligence into a single curated destination.

Research Innovation Startups Regulation Journals Tech
Scattered pharma information unified
02

We don’t compete for every story.

We connect the stories, respect the original sources, and ensure that every authentic voice in the industry gets the recognition it deserves.

Connecting voices and respecting sources
1000+
Curated Intelligence
Global & domestic sources tracked daily
24+
Industry Pillars
Research, Startups, Regulation, Policy, Journals, Tech
100%
Original Attribution
Integrity & source respect guaranteed

Meet Our Experts

Julia Naroz
Front Face

Julia Naroz

Front Face
Bharadhawaj Mukesh
News & Media Coverage

Bharadhawaj Mukesh

News & Media Coverage
Amrit Dubey
Camera & Mice Expert

Amrit Dubey

Camera & Mice Expert
Mrs. Priya Devi
Editor in Chief Digital Media

Mrs. Priya Devi

Editor in Chief Digital Media
Mrs. Shalini Bisht
Pharma & Consultant

Mrs. Shalini Bisht

Pharma & Consultant
Mr. Roopesh Sachan
Behind the Curtain

Mr. Roopesh Sachan

Behind the Curtain
Voice of Pharma ecosystem
Discover • Connect • Appreciate • Credit • Create

One Pharma World. Many Voices. One Place.

[vop_live_chat]